Clinical Trial
NCT05271409 Recruiting, Active
Meteoroid
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab As Monotherapy Or In Addition To Baseline Therapy In Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Disease
Disease type
MOGAD
Patient type
Adult
Children
Inclusion / Exclusion
Funding
private
Members involved
ERN EYE member investigating site
HCP : Principal investigators
Charité – Universitätsmedizin Berlin, Germany
Adress
Charitépl. 1
10117 Berlin
Germany
Universitätsklinikum Düsseldorf, AöR, Germany
Adress
Moorenstraße 5
40225 Düsseldorf
Germany
Clinica Oculistica – Ospedale Policlinico San Martino IRCCS, Genova, Italy
Adress
Viale Benedetto XV, 7
16132 Genova GE
Italy